Skip to content
Organisation

Bharat Biotech International

Fact-checks in which this name appears. A name here says nothing about who made a claim.

Identified as Wikidata Q4901103

Latest fact-checks

13 fact-checks
  1. Falseaccording to Vishvas News17 May 2021Great news, Bharat Biotech's Covaxin (Made in India) has been approved for children over 12 years of age.Machine-translated from Hindi. Original: शानदार खबर, भारत बायोटेक की (मेड इन इंडिया) कोवैक्सीन को 12 साल से अधिक उम्र के बच्चों के लिए मंजूरी मिल गई है।HealthIndia
  2. Falseaccording to FACTLY12 May 2021Bharat Biotech’s Covaxin received approval to vaccinate children above 12 yearsHealthIndia
  3. Misleadingaccording to FACTLY11 January 2021190 countries have already pre-booked the Covid vaccine being manufactured in India by Bharat Biotech.Machine-translated from Telugu. Original: భారత దేశంలో భారత్ బయోటెక్ ద్వారా తయారు చేయబడుతున్న కరోనా వాక్సిన్ ని 190 దేశాలు ముందుగానే బుక్ చేసుకున్నాయిHealthIndia
  4. Misleadingaccording to FACTLY6 January 2021190 countries have pre-booked the Bharat Biotech COVID-19 vaccine that India has developedHealthIndia
  5. Misleadingaccording to FACTLY10 December 2020The central government has rejected the application seeking permission for emergency use of the coronavirus vaccine being developed by Bharat Biotech.Machine-translated from Telugu. Original: భారత్ బయోటెక్ డెవలప్ చేస్తోన్న కరోనా వ్యాక్సిన్ అత్యవసర వినియోగానికి అనుమతి ఇవ్వాలని చేసిన అప్లికేషన్ ని కేంద్ర ప్రభుత్వం తిరస్కరించిందిHealthIndia
  6. Falseaccording to FACTLY30 August 2020Vaccine for COVID-19 by Bharat Biotech will be available in the market from 15 August 2020HealthIndia
  7. Falseaccording to FACTLY30 July 2020The central government gave Bharat Biotech permission to release a Covid vaccine to the market on August 15, 2020.Machine-translated from Telugu. Original: కేంద్ర ప్రభుత్వం భారత్ బయోటెక్ సంస్థ కి కరోనా వాక్సిన్ ని 15 ఆగస్టు 2020న మార్కెట్ లోకి విడుదల చేయడానికి పర్మిషన్ ఇచ్చింది.HealthIndia
  8. Falseaccording to FACTLY15 July 2020A photo of the Bharat Biotech vice president taking the first dose of Covaxin (the indigenous experimental COVID-19 vaccine).Machine-translated from Kannada. Original: ಭಾರತ್ ಬಯೋಟೆಕ್ ಉಪಾಧ್ಯಕ್ಷರು ಕೋವ್ಯಾಕ್ಸಿನ್ (ದೇಶೀಯ ಪ್ರಾಯೋಗಿಕ ಕೋವಿಡ್-19 ಲಸಿಕೆ) ಮೊದಲ ಡೋಸ್ ತೆಗೆದುಕೊಳ್ಳುವ ಫೋಟೋ.HealthImageIndia
  9. Falseaccording to Fact Crescendo9 July 2020Bharat Biotech Vice President Dr. V.K. Srinivas, who developed the COVID-19 vaccine, is confidently conducting a clinical trial on his own body with the first dose of the medicine.Machine-translated from Malayalam. Original: കോവിഡ്-19, വാക്സിൻ വികസിപ്പിച്ച ഭാരത് ബയോടെക് വൈസ് പ്രസിഡന്‍റ് ഡോ.വി.കെ.ശ്രീനിവാസ് ആദ്യഡോസ് മരുന്ന് ആത്മവിശ്വാസത്തോടെ സ്വന്തം ശരീരത്തിൽ …HealthIndia
  10. Falseaccording to FACTLY6 July 2020As part of the clinical trials of the COVID-19 vaccine made by Bharat Biotech, the company's vice president K.V. Srinivas was the first to test the vaccine on himself.Machine-translated from Telugu. Original: భారత్ బయోటెక్ సంస్థవారు తయారు చేసిన కోవిడ్ -19 వాక్సిన్ క్లినికల్ ట్రయల్స్ లో భాగంగా ఆ సంస్థ వైస్ ప్రెసిడెంట్ కే.వీ.శ్రీనివాస్ మొదట ఆ …HealthIndia
  11. Falseaccording to Youturn4 July 2020Covaxin is India's first corona vaccine trial, and heartfelt congratulations to Dr. Srinivas, Vice President of Bharat Biotech; let's pray that only good things happen.Machine-translated from Tamil. Original: கோவாக்ஸின் இந்தியாவின் முதல் கொரோனா தடுப்பூசி பரிசோதனை. நெஞ்சார்ந்த நல்வாழ்த்துக்கள் டாக்டர் ஸ்ரீநிவாஸ் சார. பாரத் பயோடெக் துணை தலைவர் …HealthIndia
  12. Falseaccording to FACTLY4 July 2020Photo of Bharat Biotech Vice President taking COVAXIN (indigenous experimental COVID-19 vaccine) first doseHealthImageIndia
  13. Falseaccording to The Quint4 July 2020Did a VP of Bharat Biotech take part in the clinical trial of the coronavirus vaccine?Machine-translated from Hindi. Original: क्या भारत बायोटेक के VP ने कोरोना वायरस वैक्सीन का क्लीनिकल ट्रायल लिया?HealthIndia

All fact-checks with this name, with filters